IOVANCE BIOTHERAPEUTICS, INC. (IOVA) stock — the fundamentals (P/E, market cap, valuation) and every material event, decoded in plain English.
Key numbers for IOVANCE BIOTHERAPEUTICS, INC. (IOVA): P/E ratio, market cap, profit margins, returns, and whether the stock looks cheap or expensive versus its own 5-year range.
AllSight quality score: 41/100 — a percentile rank of IOVANCE BIOTHERAPEUTICS, INC.’s fundamentals against Manufacturing peers, weakest on profitability. A quality ranking, not a price prediction.
| Market cap | $6.4B |
| P / S | 19.8× |
| EV / EBITDA | -24.4× |
| Gross margin | 48.4% |
| Operating margin | -92.7% |
| Net margin | -89.1% |
| Return on equity | -39.3% |
| ROIC | -47.5% |
| Revenue growth | 34.5% |
| Debt / equity | 0.0× |
| Dividend yield | 0.0% |
Is IOVANCE BIOTHERAPEUTICS, INC. overvalued? P/S looks fair vs its 5-year range; P/B looks overvalued vs its 5-year range.
Independent of the events above — derived from IOVANCE BIOTHERAPEUTICS, INC.’s own financial statements and shown as context, never as advice.
About AllSight · Editorial standards & method · Contact